Asensus Surgical, Inc. (ASXC)

Asensus Surgical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	8.72	8.58	7.09	8.23	3.18	8.53
Revenue Growth (YoY)	24.68%	21.02%	-13.91%	159.28%	-62.78%	-64.60%
Cost of Revenue	13.26	13.16	10.87	11.1	5.17	20.73
Gross Profit	-4.54	-4.58	-3.79	-2.86	-1.99	-12.2
Selling, General & Admin	34.07	36.08	34.93	32.72	27.2	46.77
Research & Development	34.98	37.02	28.94	19.35	16.62	22.47
Other Operating Expenses	0.83	0.83	9.14	11.25	11.65	82.69
Operating Expenses	69.88	73.93	73.01	63.32	55.47	151.93
Operating Income	-74.42	-78.5	-76.79	-66.18	-57.47	-164.13
Interest Expense / Income	0	0	0.41	0.37	0.02	3.61
Other Expense / Income	4.03	-0.39	-1.96	-4.32	3.34	-10.41
Pretax Income	-78.44	-78.12	-75.24	-62.24	-60.83	-157.33
Income Tax	0.27	0.31	0.32	0.23	-1.52	-3.12
Net Income	-78.71	-78.43	-75.56	-62.46	-59.31	-154.2
Preferred Dividends	0	0	0	0	0.71	0
Net Income Common	-78.71	-78.43	-75.56	-62.46	-60.02	-154.2
Shares Outstanding (Basic)	269	250	236	227	71	18
Shares Outstanding (Diluted)	269	250	236	227	71	18
Shares Change	13.00%	5.58%	4.20%	220.52%	299.22%	11.29%
EPS (Basic)	-0.30	-0.31	-0.32	-0.28	-0.85	-8.69
EPS (Diluted)	-0.30	-0.31	-0.32	-0.28	-0.85	-8.69
Free Cash Flow	-60.88	-64.19	-60.22	-42.03	-46.68	-57.96
Free Cash Flow Per Share	-0.23	-0.26	-0.26	-0.18	-0.66	-3.27
Gross Margin	-52.04%	-53.38%	-53.41%	-34.79%	-62.71%	-143.01%
Operating Margin	-852.99%	-915.29%	-1083.59%	-803.98%	-1809.92%	-1923.90%
Profit Margin	-902.25%	-914.46%	-1066.19%	-758.77%	-1890.49%	-1807.54%
Free Cash Flow Margin	-697.89%	-748.37%	-849.67%	-510.53%	-1470.17%	-679.36%
EBITDA	-74.68	-74.39	-63.76	-47.76	-47.11	-141.25
EBITDA Margin	-856.08%	-867.32%	-899.63%	-580.13%	-1483.78%	-1655.74%
Depreciation & Amortization	3.76	3.73	11.08	14.11	13.7	12.47
EBIT	-78.44	-78.12	-74.83	-61.87	-60.81	-153.72
EBIT Margin	-899.16%	-910.80%	-1055.92%	-751.54%	-1915.24%	-1801.88%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).